Pangaea is Selected by the UK Government as a Leading Digital Health Innovator

Global Pharmaceutical Proves Pangaea’s AI

Microsoft Interviews Our Founder

Identifying 6x More Cancer Patients with Cachexia in a Privacy Preserving Manner

About Pangaea Data Limited 

Pangaea Data Limited provides a machine learning based software product to its customers  from the biopharmaceutical and healthcare industry for faster identification of patient  cohorts based on phenotypes (clinical characteristics and symptoms) from electronic health  records (EHRs) and unstructured doctors’ notes. This is critical for detecting patients at risk  of diseases, finding genes linked to a phenotype in the context of drug or biomarker  discovery, recruiting patients for clinical trials, conducting real world evidence (RWE) studies  and matching the right patients with the right drugs. The company’s product has  demonstrated that it is able to find the right patient cohorts at 50x speed and 30% higher  accuracy when compared to alternative methodologies, such as rule based natural language  processing (NLP), keyword extraction and manual means. All such work and metrics are  published in high impact peer reviewed journals accessible through

Pangaea is based in San Francisco, London and Hong Kong and was founded by serial  entrepreneurs who have raised more than £130 million through their work and is advised by  leading experts from industry, Imperial College London and Stanford University. Pangaea’s  investors include leading Deep Tech and Life Science funds and serial entrepreneurs who  founded several UK and US headquartered unicorns. Pangaea has access to more than 500  million patient electronic health records through its partnerships with hospitals and other  such providers from the US, UK, Europe, South America and Asia Pacific. 

The Role 

An opportunity to facilitate the communication of our product, its novel unsupervised AI  methods and application in the context of our mission to improve patient outcomes to our  customers and partners from the Biopharmaceutical and healthcare industry. This requires a deep understanding of the product to assess its positioning and launch, and the ability to  monitor its visibility post-launch and respond to feedback. This role will involve working  closely with Pangaea’s founders and technical leads in developing a strong product  marketing copy, which speaks to both customers and a wider audience, employing excellent  written and oral skills. You will be fluent in communicating the product story and have an ability to relay the unique value proposition and its features of our product to customers and partners.  

What You’ll Do 


Perks And Benefits 

Application Contact Information 

This position will be highly visible to senior management within our company and our  investor’s organisations. 

Your application should be in English and include a cover letter highlighting your  experiences along with your CV. 

Please send your latest resume along with a cover letter to 

General Information 

Pangaea Data is an equal opportunity employer. All qualified applicants will receive  consideration for employment without regard to race, colour, sex, sexual orientation,  gender identity or expression, religion, national origin or ancestry, age, disability, marital  status, pregnancy, protected veteran status, protected genetic information, political  affiliation, or any other characteristics protected by local laws, regulations, or ordinances.